{"schema_version":"alpha-company-profile-public-v2","slug":"alumis-inc","canonical_url":"https://registry.alpha.ac/companies/alumis-inc","published_on":"2026-09-13T04:46:01.80734+00:00","last_reviewed_on":"2026-09-13T04:46:01.80734+00:00","identity":{"legal_name":"ALUMIS INC.","display_name":"ALUMIS INC.","headline":"Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.","description":"Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibo","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001847367","logo":"https://cdn.brandfetch.io/ticker/alms/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/alms/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"ALUMIS INC. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-13T04:46:01.80734+00:00"},"security_listings":[{"ticker":"ALMS","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"ALUMIS INC.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Industry","value":"Biotechnology","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/alumis-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-13T04:46:01.80734+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":13,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":13,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":13,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":13,"corroborated_claims":0,"sources":2,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-13T04:46:01.80734+00:00","observed_at":"2026-09-13T04:46:01.80734+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"alumis-inc","canonical_url":"https://registry.alpha.ac/companies/alumis-inc"},"publication":{"published_at":"2026-09-13T04:46:01.80734+00:00","last_reviewed_at":"2026-09-13T04:46:01.80734+00:00","as_of":"2026-09-13T04:46:01.80734+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/alumis-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/alumis-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/alumis-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"alumis-inc","canonical_url":"https://registry.alpha.ac/companies/alumis-inc","as_of":"2026-09-13T04:46:01.80734+00:00","last_reviewed_at":"2026-09-13T04:46:01.80734+00:00","identity":{"legal_name":"ALUMIS INC.","display_name":"ALUMIS INC.","description":"Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibo","jurisdiction":null,"country":"US","sector":"Healthcare","industry":"Biotechnology","website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001847367","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"ALMS","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"a20adb32-0417-466d-9574-50f266a4d26a","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-13","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"alan-b-colowick-m-d-m-p-h","display_name":"Alan B. Colowick, M.D., M.P.H.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null},{"person_slug":"james-b-tananbaum-m-d","display_name":"James B. Tananbaum, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null},{"person_slug":"lynn-tetrault-j-d","display_name":"Lynn Tetrault, J.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null},{"person_slug":"martin-babler-iii","display_name":"Martin Babler III","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null},{"person_slug":"patrick-machado-j-d","display_name":"Patrick Machado, J.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null},{"person_slug":"sapna-srivastava","display_name":"Sapna Srivastava","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null},{"person_slug":"srinivas-akkaraju-m-d-ph-d","display_name":"Srinivas Akkaraju, M.D., Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null},{"person_slug":"zhengbin-bing-yao-ph-d","display_name":"Zarath Summers, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"ALUMIS INC. DEF 14A 2025-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2025-06-16","last_checked_at":"2026-04-24T16:15:03.103+00:00"},"headshot_url":null}],"executives":[],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"NOT_ASSERTED","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/alumis-inc#profile","url":"https://registry.alpha.ac/companies/alumis-inc","dateModified":"2026-09-13T04:46:01.80734+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/alumis-inc#organization","legalName":"ALUMIS INC.","name":"ALUMIS INC.","description":"Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibo","url":"https://registry.alpha.ac/companies/alumis-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Alan B. Colowick, M.D., M.P.H.","url":"https://registry.alpha.ac/people/alan-b-colowick-m-d-m-p-h"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"James B. Tananbaum, M.D.","url":"https://registry.alpha.ac/people/james-b-tananbaum-m-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","member":{"@type":"Person","name":"Lynn Tetrault, J.D.","url":"https://registry.alpha.ac/people/lynn-tetrault-j-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Martin Babler III","url":"https://registry.alpha.ac/people/martin-babler-iii"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","member":{"@type":"Person","name":"Patrick Machado, J.D.","url":"https://registry.alpha.ac/people/patrick-machado-j-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Sapna Srivastava","url":"https://registry.alpha.ac/people/sapna-srivastava"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2024-01-01","member":{"@type":"Person","name":"Srinivas Akkaraju, M.D., Ph.D.","url":"https://registry.alpha.ac/people/srinivas-akkaraju-m-d-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Zarath Summers, Ph.D.","url":"https://registry.alpha.ac/people/zhengbin-bing-yao-ph-d"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/alumis-inc"}},"canonical_source":"aegis_canonical"}